Reelin is reported to control tau phosphorylation through ApoE-receptor 2/disabled-1/GSK-3β in neurodegeneration diseases, such as Alzheimer’s disease (Ohkubo et al., 2003), but this neuroprotective effect is still unclear in ischemic stroke. Here, MAPT is linked to ischemic stroke.